Integer Holdings (ITGR) witnessed strong momentum year to date. Shares of the company have gained 21.9% compared with 5.4% growth of the industryin the same time frame. The S&P 500 Composite has risen 14.3% during the same period. With healthy fundamentals and strong growth opportunities, this Zacks Rank #3 (Hold) company appears to be a solid wealth creator for its investors at the moment. Plano, TX-based Integer Holdings manufactures and develops medical devices and components primarily for original equip ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Za ...

~ Report Highlights Integer's Commitment to Minimizing Environmental Footprint, Maximizing Positive Global Impact and Enhancing the Lives of Patients Worldwide ~ PLANO, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced the release of its first environmental, social and governance (ESG) report, "Making a Difference: Integer's Inaugural Impact Report." "I am excited to ...

~ Report Highlights Integer's Commitment to Minimizing Environmental Footprint, Maximizing Positive Global Impact and Enhancing the Lives of Patients Worldwide ~ PLANO, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced the release of its first environmental, social and governance (ESG) report, "Making a Difference: Integer's Inaugural Impact Report." "I am excited to ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. It also includes access to the Zacks Style Scores. What are ...

The adjustments include expenses related to the amortization of intangible assets and restructuring and restructuring-related charges, among others. Revenues in Detail Organically, revenues increased 5.2%. Segmental Analysis Medical Sales reported revenues of $427.4 million, up 9.8% year over year on a reported and 5.9% on an organic basis. This figure compares to our Medical Sales second-quarter projection of $430 million. Integer Holdings' AS&O revenues amounted to $28.4 million, up 4.4% year over year on ...

Integer Holdings Corporation (NYSE:ITGR) Q2 2024 Earnings Conference Call July 25, 2024 9:00 AM ET Company Participants Andrew Senn - Senior Vice President, Strategy, Business Development and Investor Relations Joseph Dziedzic - President and Chief Executive Officer Diron Smith - Chief Financial Officer Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Craig Bijou - BofA Securities Matthew O’Brien - Piper Sandler Companies Richard Newitter - Truist Securities Kristen Stewart - C.L. King & ...

The reported revenue represents a surprise of -0.44% over the Zacks Consensus Estimate of $438.15 million. With the consensus EPS estimate being $1.24, the EPS surprise was +4.84%. Here is how Integer performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Shares of Integer have returned +8.5% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could under ...

Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the shortterm price performance of a stock. The average prediction of analysts places 'Sales- Medical Sales- Cardiac Rhythm Management & Neuromodulation' at $168.14 million. The estimate ...

Over the last four quarters, the company has surpassed consensus EPS estimates four times. Integer shares have added about 25.7% since the beginning of the year versus the S&P 500's gain of 13.8%. There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Investors should be min ...